Slow coronary flow. Other forms of angina pectoris
Conditions
Interventions
Intervention 1: Intervention group: In this group, in addition to common medications, patients in the intervention group will be given 60 mg of diltiazem orally every 12 hours as one tablet for six mo
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Diagnostic angiography due to chronic symptoms or a positive non-invasive stress test, in which the contrast agent has not yet reached the end of the coronary arteries despite 3 heartbeats during angiography, or the patient has a TIMI frame count greater than 27 during angiography. No history of MI or prior revascularization
Exclusion criteria
Exclusion criteria: Cardiomyopathy with an ejection fraction below 40%. History of allergy to diltiazem Systolic blood pressure less than or equal to 90 mmHg Moderate or severe valvular heart disease Congenital heart disease Coronary artery stenosis of more than 50% or coronary artery ectasia Bradycardia with a heart rate below 60 Angina pectoris with NYHA classification 3 and 4 2nd and 3rd degree atrioventricular block
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms of patients including chest pain, functional chest pain and functional shortness of breath and 6-minute walking test. Timepoint: Six month after the first visit and drug consumption. Method of measurement: Evaluation and questioning of patients by a specialist doctor and registration in the checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbdolhadi Aref
Tehran University of Medical Sciences
Outcome results
None listed